相似文献
1
Secreting tumor suppression.
Cell. 2008 Feb 8;132(3):339-41. doi: 10.1016/j.cell.2008.01.022.
2
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.
Cell. 2008 Feb 8;132(3):363-74. doi: 10.1016/j.cell.2007.12.032.
3
Role for IGFBP7 in senescence induction by BRAF.
Cell. 2010 May 28;141(5):746-7. doi: 10.1016/j.cell.2010.05.014.
4
Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes.
Elife. 2020 Oct 13;9:e61026. doi: 10.7554/eLife.61026.
5
Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
Hum Pathol. 2010 Jun;41(6):886-94. doi: 10.1016/j.humpath.2009.12.002. Epub 2010 Mar 16.
6
IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Cell. 2010 May 14;141(4):717-27. doi: 10.1016/j.cell.2010.04.021.
7
Lack of correlation between IGFBP7 expression and BRAF mutational status in melanoma.
J Invest Dermatol. 2010 Mar;130(3):897-8. doi: 10.1038/jid.2009.304. Epub 2009 Oct 15.
8
Oncogenic Braf induces melanocyte senescence and melanoma in mice.
Cancer Cell. 2009 Apr 7;15(4):294-303. doi: 10.1016/j.ccr.2009.02.022.
9
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Genes Dev. 2012 May 15;26(10):1055-69. doi: 10.1101/gad.187252.112. Epub 2012 May 1.
10
Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
J Cutan Pathol. 2010 Mar;37(3):344-9. doi: 10.1111/j.1600-0560.2009.01433.x. Epub 2009 Sep 24.
引用本文的文献
1
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer.
Oncogene. 2012 Mar 22;31(12):1599-608. doi: 10.1038/onc.2011.350. Epub 2011 Aug 22.
2
The double-edged sword of autophagy modulation in cancer.
Clin Cancer Res. 2009 Sep 1;15(17):5308-16. doi: 10.1158/1078-0432.CCR-07-5023. Epub 2009 Aug 25.
3
Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action.
Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H893-901. doi: 10.1152/ajpheart.00414.2009. Epub 2009 Jul 10.
本文引用的文献
1
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.
Cell. 2008 Feb 8;132(3):363-74. doi: 10.1016/j.cell.2007.12.032.
2
Oncogene addiction: setting the stage for molecularly targeted cancer therapy.
Genes Dev. 2007 Dec 15;21(24):3214-31. doi: 10.1101/gad.1609907.
3
Cellular senescence: when bad things happen to good cells.
Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40. doi: 10.1038/nrm2233.
4
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
Nature. 2007 Feb 8;445(7128):656-60. doi: 10.1038/nature05529. Epub 2007 Jan 24.
5
A negative feedback signaling network underlies oncogene-induced senescence.
Cancer Cell. 2006 Dec;10(6):459-72. doi: 10.1016/j.ccr.2006.10.003.
6
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.
Nat Cell Biol. 2006 Aug;8(8):877-84. doi: 10.1038/ncb1448. Epub 2006 Jul 23.
7
Senescence comes of age.
Nat Med. 2005 Sep;11(9):920-2. doi: 10.1038/nm0905-920.
8
Intrinsic tumour suppression.
Nature. 2004 Nov 18;432(7015):307-15. doi: 10.1038/nature03098.
9
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.
Exp Cell Res. 1965 Mar;37:614-36. doi: 10.1016/0014-4827(65)90211-9.
10
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12072-7. doi: 10.1073/pnas.211053698. Epub 2001 Oct 2.
Zotero 插件